|
US4526988A
(en)
|
1983-03-10 |
1985-07-02 |
Eli Lilly And Company |
Difluoro antivirals and intermediate therefor
|
|
US5246924A
(en)
|
1987-09-03 |
1993-09-21 |
Sloan-Kettering Institute For Cancer Research |
Method for treating hepatitis B virus infections using 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-ethyluracil
|
|
SE8802687D0
(sv)
|
1988-07-20 |
1988-07-20 |
Astra Ab |
Nucleoside derivatives
|
|
US6060592A
(en)
|
1990-01-11 |
2000-05-09 |
Isis Pharmaceuticals, Inc. |
Pyrimidine nucleoside compounds and oligonucleoside compounds containing same
|
|
US6060542A
(en)
|
1997-05-16 |
2000-05-09 |
Shell Oil Company |
Bitumen compositions and a process for their preparation
|
|
WO1999043691A1
(en)
|
1998-02-25 |
1999-09-02 |
Emory University |
2'-fluoronucleosides
|
|
MY164523A
(en)
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
|
EA005890B1
(ru)
|
2000-05-26 |
2005-06-30 |
Айденикс (Кайман) Лимитед |
СПОСОБЫ ЛЕЧЕНИЯ ИНФЕКЦИЙ, ВЫЗЫВАЕМЫХ ВИРУСОМ ГЕПАТИТА ДЕЛЬТА, С ИСПОЛЬЗОВАНИЕМ β-L-2'-ДЕЗОКСИНУКЛЕОЗИДОВ
|
|
EP1736478B1
(en)
|
2000-05-26 |
2015-07-22 |
IDENIX Pharmaceuticals, Inc. |
Methods and compositions for treating flaviviruses and pestiviruses
|
|
US6787526B1
(en)
|
2000-05-26 |
2004-09-07 |
Idenix Pharmaceuticals, Inc. |
Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosides
|
|
US20030008841A1
(en)
|
2000-08-30 |
2003-01-09 |
Rene Devos |
Anti-HCV nucleoside derivatives
|
|
WO2002028862A2
(en)
*
|
2000-10-02 |
2002-04-11 |
Emory University |
Triptolide analogs for the treatment of autoimmune and inflammatory disorders
|
|
WO2002032920A2
(en)
|
2000-10-18 |
2002-04-25 |
Pharmasset Limited |
Modified nucleosides for treatment of viral infections and abnormal cellular proliferation
|
|
US8481712B2
(en)
|
2001-01-22 |
2013-07-09 |
Merck Sharp & Dohme Corp. |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
|
US7105499B2
(en)
|
2001-01-22 |
2006-09-12 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
|
SK286630B6
(sk)
|
2001-01-22 |
2009-02-05 |
Merck & Co., Inc. |
Nukleozidové deriváty, farmaceutický prostriedok s ich obsahom a ich použitie
|
|
EP1435974A4
(en)
|
2001-09-28 |
2006-09-06 |
Idenix Cayman Ltd |
METHODS AND COMPOSITIONS FOR THE TREATMENT OF HEPATITIS C VIRUS USING 4 'MODIFIED NUCLEOSIDES
|
|
WO2003105770A2
(en)
|
2002-06-17 |
2003-12-24 |
Merck & Co., Inc. |
Carbocyclic nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
|
WO2004000858A2
(en)
|
2002-06-21 |
2003-12-31 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
|
US7608600B2
(en)
|
2002-06-28 |
2009-10-27 |
Idenix Pharmaceuticals, Inc. |
Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
|
|
CN1678326A
(zh)
|
2002-06-28 |
2005-10-05 |
埃迪尼克斯(开曼)有限公司 |
用于治疗黄病毒感染的2'-c-甲基-3'-o-l-缬氨酸酯核糖呋喃基胞苷
|
|
LT1576138T
(lt)
|
2002-11-15 |
2017-06-26 |
Idenix Pharmaceuticals Llc |
2`-šakoti nukleozidai derinyje su interferonu ir flaviviridae mutacija
|
|
AU2003300901A1
(en)
|
2002-12-12 |
2004-06-30 |
Idenix (Cayman) Limited |
Process for the production of 2'-branched nucleosides
|
|
WO2004084453A2
(en)
*
|
2003-03-20 |
2004-09-30 |
Microbiologica Quimica E Farmaceutica Ltd. |
METHODS OF MANUFACTURE OF 2'-DEOXY-β-L-NUCLEOSIDES
|
|
HUE029877T2
(en)
|
2003-05-30 |
2017-04-28 |
Gilead Pharmasset Llc |
Modified fluorinated nucleoside analogues
|
|
GB0317009D0
(en)
|
2003-07-21 |
2003-08-27 |
Univ Cardiff |
Chemical compounds
|
|
WO2006063149A1
(en)
|
2004-12-09 |
2006-06-15 |
Regents Of The University Of Minnesota |
Nucleosides with antiviral and anticancer activity
|
|
US7250416B2
(en)
|
2005-03-11 |
2007-07-31 |
Supergen, Inc. |
Azacytosine analogs and derivatives
|
|
WO2006121820A1
(en)
|
2005-05-05 |
2006-11-16 |
Valeant Research & Development |
Phosphoramidate prodrugs for treatment of viral infection
|
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
|
PA8852101A1
(es)
|
2008-12-08 |
2010-07-27 |
Medivir Ab |
Nucleótidos uracil ciclopropílicos
|
|
TWI583692B
(zh)
|
2009-05-20 |
2017-05-21 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
|
US8618076B2
(en)
|
2009-05-20 |
2013-12-31 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
|
EA020031B1
(ru)
|
2009-06-11 |
2014-08-29 |
Эббви Бахамаз Лтд. |
Противовирусные соединения
|
|
US8937150B2
(en)
|
2009-06-11 |
2015-01-20 |
Abbvie Inc. |
Anti-viral compounds
|
|
US9790252B2
(en)
|
2009-07-01 |
2017-10-17 |
Cornell University |
2-fluorinated riboses and arabinoses and methods of use and synthesis
|
|
US8846673B2
(en)
*
|
2009-08-11 |
2014-09-30 |
Bristol-Myers Squibb Company |
Azaindazoles as kinase inhibitors and use thereof
|
|
US9700560B2
(en)
|
2009-11-16 |
2017-07-11 |
University Of Georgia Research Foundation, Inc. |
2′-fluoro-6′-methylene carbocyclic nucleosides and methods of treating viral infections
|
|
SG184324A1
(en)
*
|
2010-03-31 |
2012-11-29 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
|
WO2012040126A1
(en)
*
|
2010-09-22 |
2012-03-29 |
Alios Biopharma, Inc. |
Substituted nucleotide analogs
|
|
CA2818853A1
(en)
|
2010-11-30 |
2012-06-07 |
Gilead Pharmasset Llc |
2'-spirocyclo-nucleosides for use in therapy of hcv or dengue virus
|
|
US9156874B2
(en)
*
|
2011-01-03 |
2015-10-13 |
Nanjing Molecular Research, Inc. |
Double-liver-targeting phosphoramidate and phosphonoamidate prodrugs
|
|
US9243025B2
(en)
|
2011-03-31 |
2016-01-26 |
Idenix Pharmaceuticals, Llc |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
|
BR112013026345A2
(pt)
|
2011-04-13 |
2019-04-24 |
Merck Sharp & Dohe Corp. |
composto, composição farmacêutica, uso de um composto, e, método para tratar um paciente infectado com hcv
|
|
US8877733B2
(en)
*
|
2011-04-13 |
2014-11-04 |
Gilead Sciences, Inc. |
1′-substituted pyrimidine N-nucleoside analogs for antiviral treatment
|
|
US8889159B2
(en)
|
2011-11-29 |
2014-11-18 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis C virus
|
|
US20130143835A1
(en)
*
|
2011-12-05 |
2013-06-06 |
Medivir Ab |
HCV Polymerase Inhibitors
|
|
AU2012357940B2
(en)
*
|
2011-12-20 |
2017-02-16 |
Riboscience Llc |
2',4'-difluoro-2'-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication
|
|
MX350810B
(es)
*
|
2011-12-20 |
2017-09-20 |
Riboscience Llc |
Derivados de los nucleosidos sustituidos en 4 '-azido, 3 '-fluoro como inhibidores de la replicacion del rna del vhc.
|
|
CN104640444B
(zh)
*
|
2012-06-16 |
2016-12-14 |
河南美泰宝生物制药有限公司 |
双肝脏靶向氨基磷酸酯和氨基膦酸酯前药
|
|
CN102751200B
(zh)
|
2012-06-29 |
2015-06-10 |
京东方科技集团股份有限公司 |
薄膜晶体管、阵列基板及其制造方法
|
|
US20140065101A1
(en)
*
|
2012-08-31 |
2014-03-06 |
Novartis Ag |
2'-Branched Nucleosides for Treatment of Viral Infections
|
|
EP2906579B1
(en)
|
2012-10-08 |
2018-04-18 |
Idenix Pharmaceuticals LLC. |
2'-chloro nucleoside analogs for hcv infection
|
|
AR092959A1
(es)
|
2012-10-17 |
2015-05-06 |
Merck Sharp & Dohme |
Derivados de nucleosidos 2-metil sustituidos y metodos de uso de los mismos para el tratamiento de enfermedades virales
|
|
EP2935304A1
(en)
|
2012-12-19 |
2015-10-28 |
IDENIX Pharmaceuticals, Inc. |
4'-fluoro nucleosides for the treatment of hcv
|
|
BR112015014457A2
(pt)
|
2012-12-21 |
2017-11-21 |
Alios Biopharma Inc |
composto ou sal farmaceuticamente aceitável do mesmo e composição farmacêutica e respectivos usos e processos para melhorar ou tratar infecção de hcv, para inibir a atividade da ns5b polimerase do vírus da hepatite c e a replicação de vírus da hepatite c
|
|
US10034893B2
(en)
|
2013-02-01 |
2018-07-31 |
Enanta Pharmaceuticals, Inc. |
5, 6-D2 uridine nucleoside/tide derivatives
|
|
US9447132B2
(en)
|
2013-04-12 |
2016-09-20 |
Achillion Pharmaceuticals, Inc. |
Highly active nucleoside derivative for the treatment of HCV
|
|
AU2014302711A1
(en)
|
2013-06-26 |
2015-12-10 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
|
UA117375C2
(uk)
*
|
2013-09-04 |
2018-07-25 |
Медівір Аб |
Інгібітори полімерази hcv
|
|
LT3043803T
(lt)
|
2013-09-11 |
2022-08-10 |
Emory University |
Nukleotidų ir nukleozidų kompozicijos ir jų panaudojimas
|
|
WO2015054465A1
(en)
|
2013-10-11 |
2015-04-16 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
|
WO2015056213A1
(en)
*
|
2013-10-17 |
2015-04-23 |
Medivir Ab |
Hcv polymerase inhibitors
|
|
WO2015077360A2
(en)
*
|
2013-11-20 |
2015-05-28 |
Idenix Pharmaceuticals, Inc. |
Cyclopentane and cyclopentene nucleoside analogs for the treatment of hcv
|
|
EP3074399A1
(en)
|
2013-11-27 |
2016-10-05 |
Idenix Pharmaceuticals LLC |
2'-dichloro and 2'-fluoro-2'-chloro nucleoside analogues for hcv infection
|
|
WO2015120014A1
(en)
*
|
2014-02-05 |
2015-08-13 |
Merck Sharp & Dohme Corp. |
Novel disintegration systems for pharmaceutical dosage forms
|
|
US10202411B2
(en)
|
2014-04-16 |
2019-02-12 |
Idenix Pharmaceuticals Llc |
3′-substituted methyl or alkynyl nucleosides nucleotides for the treatment of HCV
|
|
CN106536538A
(zh)
|
2014-04-24 |
2017-03-22 |
共晶制药股份有限公司 |
用于治疗黄病毒家族病毒和癌症的2’‑双取代核苷类似物
|
|
CN107108683A
(zh)
|
2014-10-31 |
2017-08-29 |
共晶制药股份有限公司 |
用于治疗黄病毒科病毒和癌症的2’,2’‑二卤代核苷类似物
|
|
CA2984421C
(en)
|
2015-05-01 |
2024-04-09 |
Cocrystal Pharma, Inc. |
Nucleoside analogs for treatment of the flaviviridae family of viruses and cancer
|
|
JP6743135B2
(ja)
*
|
2015-09-02 |
2020-08-19 |
アッヴィ・インコーポレイテッド |
抗ウィルス性テトラヒドロフラン誘導体
|